1
|
Feng Báez JP, George De la Rosa MV, Alvarado-Hernández BB, Romañach RJ, Stelzer T. Evaluation of a compact composite sensor array for concentration monitoring of solutions and suspensions via multivariate analysis. J Pharm Biomed Anal 2023; 233:115451. [PMID: 37182364 DOI: 10.1016/j.jpba.2023.115451] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/25/2023] [Revised: 04/24/2023] [Accepted: 05/07/2023] [Indexed: 05/16/2023]
Abstract
Compact composite probes were identified as a priority to alleviate space constraints in miniaturized unit operations and pharmaceutical manufacturing platforms. Therefore, in this proof of principle study, a compact composite sensor array (CCSA) combining ultraviolet and near infrared features at four different wavelengths (280, 340, 600, 860 nm) in a 380 × 30 mm housing (length x diameter, 7 mm diameter at the probe head), was evaluated for its capabilities to monitor in situ concentration of solutions and suspensions via multivariate analysis using partial least squares (PLS) regression models. Four model active pharmaceutical ingredients (APIs): warfarin sodium isopropanol solvate (WS), lidocaine hydrochloride monohydrate (LID), 6-mercaptopurine monohydrate (6-MP), and acetaminophen (ACM) in their aqueous solution and suspension formulation were used for the assessment. The results demonstrate that PLS models can be applied for the CCSA prototype to measure the API concentrations with similar accuracy (validation samples within the United States Pharmacopeia (USP) limits), compared to univariate CCSA models and multivariate models for an established Raman spectrometer. Specifically, the multivariate CCSA models applied to the suspensions of 6-MP and ACM demonstrate improved accuracy of 63% and 31%, respectively, compared to the univariate CCSA models [1]. On the other hand, the PLS models for the solutions WS and LID showed a reduced accuracy compared to the univariate models [1].
Collapse
Affiliation(s)
- Jean P Feng Báez
- Department of Pharmaceutical Sciences, School of Pharmacy, University of Puerto Rico, Medical Sciences Campus, San Juan, PR 00936, USA; Crystallization Design Institute, Molecular Sciences Research Center, University of Puerto Rico, San Juan, PR 00926, USA
| | - Mery Vet George De la Rosa
- Department of Pharmaceutical Sciences, School of Pharmacy, University of Puerto Rico, Medical Sciences Campus, San Juan, PR 00936, USA; Crystallization Design Institute, Molecular Sciences Research Center, University of Puerto Rico, San Juan, PR 00926, USA
| | | | - Rodolfo J Romañach
- Department of Chemistry, University of Puerto Rico, Mayagüez Campus, Mayagüez, PR 00681, USA
| | - Torsten Stelzer
- Department of Pharmaceutical Sciences, School of Pharmacy, University of Puerto Rico, Medical Sciences Campus, San Juan, PR 00936, USA; Crystallization Design Institute, Molecular Sciences Research Center, University of Puerto Rico, San Juan, PR 00926, USA.
| |
Collapse
|
2
|
Scott D, Briggs NEB, Formosa A, Burnett A, Desai B, Hammersmith G, Rapp K, Capellades G, Myerson AS, Roper TD. Impurity Purging through Systematic Process Development of a Continuous Two-Stage Crystallization. Org Process Res Dev 2023. [DOI: 10.1021/acs.oprd.2c00317] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/05/2023]
Affiliation(s)
- Drew Scott
- Department of Chemical and Life Science Engineering, Virginia Commonwealth University, Richmond, Virginia23284, United States
| | - Naomi E. B. Briggs
- On Demand Pharmaceuticals, 1550 E Gude Drive, Rockville, Maryland20850, United States
| | - Anna Formosa
- On Demand Pharmaceuticals, 1550 E Gude Drive, Rockville, Maryland20850, United States
| | - Annessa Burnett
- Department of Chemical and Life Science Engineering, Virginia Commonwealth University, Richmond, Virginia23284, United States
| | - Bimbisar Desai
- TCG GreenChem, Inc., 701 Charles Ewing Boulevard, Ewing, New Jersey08628, United States
| | - Greg Hammersmith
- On Demand Pharmaceuticals, 1550 E Gude Drive, Rockville, Maryland20850, United States
| | - Kersten Rapp
- On Demand Pharmaceuticals, 1550 E Gude Drive, Rockville, Maryland20850, United States
| | - Gerard Capellades
- Henry M. Rowan College of Engineering, Rowan University, Glassboro, New Jersey08028, United States
| | - Allan S. Myerson
- Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts02139, United States
| | - Thomas D. Roper
- Department of Chemical and Life Science Engineering, Virginia Commonwealth University, Richmond, Virginia23284, United States
| |
Collapse
|
3
|
Vinet L, Di Marco L, Kairouz V, Charette AB. Process Intensive Synthesis of Propofol Enabled by Continuous Flow Chemistry. Org Process Res Dev 2022. [DOI: 10.1021/acs.oprd.1c00416] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/05/2023]
Affiliation(s)
- Laurent Vinet
- Centre in Green Chemistry and Catalysis, Center for Continuous Flow Synthesis, Department of Chemistry, Université de Montréal, 1375, av. Thérèse Lavoie-Roux, Montréal, Québec H2V 0B3, Canada
| | - Lorenzo Di Marco
- Centre in Green Chemistry and Catalysis, Center for Continuous Flow Synthesis, Department of Chemistry, Université de Montréal, 1375, av. Thérèse Lavoie-Roux, Montréal, Québec H2V 0B3, Canada
| | - Vanessa Kairouz
- Centre in Green Chemistry and Catalysis, Center for Continuous Flow Synthesis, Department of Chemistry, Université de Montréal, 1375, av. Thérèse Lavoie-Roux, Montréal, Québec H2V 0B3, Canada
| | - André B. Charette
- Centre in Green Chemistry and Catalysis, Center for Continuous Flow Synthesis, Department of Chemistry, Université de Montréal, 1375, av. Thérèse Lavoie-Roux, Montréal, Québec H2V 0B3, Canada
| |
Collapse
|
4
|
Miyai Y, Formosa A, Armstrong C, Marquardt B, Rogers L, Roper T. PAT Implementation on a Mobile Continuous Pharmaceutical Manufacturing System: Real-Time Process Monitoring with In-Line FTIR and Raman Spectroscopy. Org Process Res Dev 2021. [DOI: 10.1021/acs.oprd.1c00299] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Affiliation(s)
- Yuma Miyai
- Department of Chemical and Life Science Engineering, Virginia Commonwealth University, Richmond, Virginia 23284-2512, United States
| | - Anna Formosa
- OnDemand Pharmaceuticals, Rockville, Maryland 20850, United States
| | - Cameron Armstrong
- Department of Chemical and Life Science Engineering, Virginia Commonwealth University, Richmond, Virginia 23284-2512, United States
| | | | - Luke Rogers
- OnDemand Pharmaceuticals, Rockville, Maryland 20850, United States
| | - Thomas Roper
- Department of Chemical and Life Science Engineering, Virginia Commonwealth University, Richmond, Virginia 23284-2512, United States
| |
Collapse
|
5
|
De la Rosa MVG, Báez JPF, Romañach RJ, López-Mejías V, Stelzer T. Real-time concentration monitoring using a compact composite sensor array for in situ quality control of aqueous formulations. J Pharm Biomed Anal 2021; 206:114386. [PMID: 34607202 DOI: 10.1016/j.jpba.2021.114386] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/14/2021] [Revised: 08/29/2021] [Accepted: 09/15/2021] [Indexed: 11/25/2022]
Abstract
Recent advancements have demonstrated the feasibility of refrigerator-sized pharmaceutical manufacturing platforms (PMPs) for integrated end-to-end manufacturing of active pharmaceutical ingredients (APIs) into formulated drug products. Unlike typical laboratory- or industrial-scale setups, PMPs present unique requirements for process analytical technology (PAT) with respect to versatility, flexibility, and physical size to fit into the PMP space constraints. In this proof of principle study, a novel compact composite sensor array (CCSA) combining ultraviolet (UV) and near infrared (NIR) features at four different wavelengths (280, 340, 600, 860 nm) with temperature measuring capability in a 380 × 30 mm housing (length x diameter, 7 mm diameter at the probe head), were evaluated. The results indicate that the CCSA prototype is capable of measuring the solution and suspension concentrations in aqueous formulations of four model APIs (warfarin sodium isopropanol solvate, lidocaine hydrochloride monohydrate, 6-mercaptopurine monohydrate, acetaminophen) in situ and in real-time with similar accuracy as an established Raman spectrometer commonly applied for method development.
Collapse
Affiliation(s)
- Mery Vet George De la Rosa
- Department of Pharmaceutical Sciences, University of Puerto Rico, Medical Sciences Campus San Juan, PR 00936, USA; Crystallization Design Institute, Molecular Sciences Research Center, University of Puerto Rico, San Juan, PR 00926, USA
| | - Jean P Feng Báez
- Department of Pharmaceutical Sciences, University of Puerto Rico, Medical Sciences Campus San Juan, PR 00936, USA; Crystallization Design Institute, Molecular Sciences Research Center, University of Puerto Rico, San Juan, PR 00926, USA
| | - Rodolfo J Romañach
- Department of Chemistry, University of Puerto Rico, Mayagüez Campus,. Mayagüez, PR, 00681, USA
| | - Vilmalí López-Mejías
- Crystallization Design Institute, Molecular Sciences Research Center, University of Puerto Rico, San Juan, PR 00926, USA; Department of Chemistry, University of Puerto Rico, Río Piedras Campus, San Juan, PR 00931, USA.
| | - Torsten Stelzer
- Department of Pharmaceutical Sciences, University of Puerto Rico, Medical Sciences Campus San Juan, PR 00936, USA; Crystallization Design Institute, Molecular Sciences Research Center, University of Puerto Rico, San Juan, PR 00926, USA.
| |
Collapse
|
6
|
Costantino RC. The U.S. medicine chest: Understanding the U.S. pharmaceutical supply chain and the role of the pharmacist. J Am Pharm Assoc (2003) 2021; 61:e87-e92. [PMID: 32819877 PMCID: PMC7434313 DOI: 10.1016/j.japh.2020.07.018] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/11/2020] [Revised: 07/14/2020] [Accepted: 07/16/2020] [Indexed: 12/03/2022]
Abstract
The U.S. capacity to manufacture key essential medications has diminished. The U.S. pharmaceutical supply chain (USPSC) has diversified and now relies on international sources of active pharmaceutical ingredients and finished drug products (FDPs). Despite years of effort raising concerns about the USPSC, pharmacists and pharmacy technicians continue to spend a substantial amount of time and energy responding to, and mitigating the impact of, medication shortages, drug recalls, and the adverse outcomes related to low-quality medications. The extent of U.S. reliance on foreign sources of medications is largely unknown. Pharmacists do not have a reliable way to determine the country of origin (i.e., source), capacity, or geographic location of pharmaceutical manufacturers, limiting our ability to anticipate challenges or mitigate risks to our Nation's drug supply. The U.S. Food and Drug Administration's task of regulating quality and safety is challenging and will likely require additional safeguards and resources. In addition to pharmacists' engagement, solutions will likely need to leverage a mix of policy, economic incentives, and expanded objective surveillance testing. The U.S. pharmaceutical supply chain is complex, global, and goes beyond FDPs. The 2020 American Pharmacists Association House of Delegates has rightly asserted that "The quality and safety of pharmaceutical and other medical products and the global pharmaceutical and medical product supply chain are essential to the United States national security and public health." Pharmacy professionals on the front line engage with patients, identify medication-related issues, and engage in drug-procurement decisions. Pharmacists are essential to our nation's overall health and must be engaged in the development and implementation of strategies to safeguard the USPSC.
Collapse
|
7
|
Fujii T, Kawasaki SI. Supercritical Carbon Dioxide Extraction of a Biaryl from Model Product Solutions of a Flow Suzuki–Miyaura Coupling Reaction. JOURNAL OF CHEMICAL ENGINEERING OF JAPAN 2020. [DOI: 10.1252/jcej.19we240] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Tatsuya Fujii
- Research Institute of Chemical Process Technology, National Institute of Advanced Industrial Science and Technology (AIST)
| | - Shin-ichiro Kawasaki
- Research Institute of Chemical Process Technology, National Institute of Advanced Industrial Science and Technology (AIST)
| |
Collapse
|
8
|
In-Hospital Production of Medicines: Preparing for Disruption. Trends Biotechnol 2019; 38:1045-1047. [PMID: 31679825 DOI: 10.1016/j.tibtech.2019.09.011] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/03/2019] [Revised: 09/20/2019] [Accepted: 09/23/2019] [Indexed: 11/23/2022]
Abstract
In-hospital production of affordable medicines holds potential to address problems of drug accessibility. However, expanding the scope of magistral preparation to include high-cost drugs and complex biologicals gives rise to new challenges. We discuss ethical and regulatory complexities faced by Dutch initiatives defying the current pharmaceutical system through magistral preparation.
Collapse
|
9
|
Bana P, Szigetvári Á, Kóti J, Éles J, Greiner I. Flow-oriented synthetic design in the continuous preparation of the aryl piperazine drug flibanserin. REACT CHEM ENG 2019. [DOI: 10.1039/c8re00266e] [Citation(s) in RCA: 16] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022]
Abstract
The first integrated continuous-flow synthesis of the drug substance flibanserin was developed, using an uninterrupted four-step sequence, via an unprecedented route.
Collapse
|
10
|
Mateos C, Nieves-Remacha MJ, Rincón JA. Automated platforms for reaction self-optimization in flow. REACT CHEM ENG 2019. [DOI: 10.1039/c9re00116f] [Citation(s) in RCA: 70] [Impact Index Per Article: 14.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Abstract
This article highlights recent progress in continuous flow self-optimizing platforms.
Collapse
Affiliation(s)
- Carlos Mateos
- Centro de Investigación Lilly S.A
- Alcobendas-Madrid 28108
- Spain
| | | | - Juan A. Rincón
- Centro de Investigación Lilly S.A
- Alcobendas-Madrid 28108
- Spain
| |
Collapse
|
11
|
Azad MA, Osorio JG, Brancazio D, Hammersmith G, Klee DM, Rapp K, Myerson A. A compact, portable, re-configurable, and automated system for on-demand pharmaceutical tablet manufacturing. Int J Pharm 2018; 539:157-164. [PMID: 29366938 DOI: 10.1016/j.ijpharm.2018.01.027] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/08/2017] [Revised: 01/08/2018] [Accepted: 01/13/2018] [Indexed: 11/17/2022]
Abstract
Due to the complex nature of the pharmaceutical supply chain, the industry faces several major challenges when it comes to ensuring an adequate supply of quality drug products. These challenges are not only the causes of supply chain disruptions and financial loss, but can also prevent underserved and remote areas from receiving life-saving drugs. As a preliminary demonstration to mitigate all these challenges, at MIT we have developed active pharmaceutical ingredients manufacturing in a miniature platform. However, manufacturing of final oral solid dosage as tablets from drug substances had not been demonstrated. In this study, a compact, portable, re-configurable, and automated tablet manufacturing system, roughly the size of a North American household oven, [72.4 cm (length) × 53.3 cm (width) × 134.6 cm (height)] was designed, built and demonstrated. This miniature system is able to manufacture on-demand tablets from drug crystals on a scale of hundreds to thousands per day. Ibuprofen and Diazepam, each having different drug loading, were manufactured using this miniature system and meet U.S. Pharmacopeia standards. We foresee this flexible, miniature, plug-and-play pharmaceutical solids dosage manufacturing system advancing on-demand ready-to-use pharmaceuticals enabling future treatment of human diseases at the point-of-care.
Collapse
Affiliation(s)
- Mohammad A Azad
- Department of Chemical Engineering, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA
| | - Juan G Osorio
- Department of Chemical Engineering, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA
| | - David Brancazio
- Department of Chemical Engineering, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA
| | - Gregory Hammersmith
- Department of Chemical Engineering, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA
| | - David M Klee
- Department of Chemical Engineering, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA
| | - Kersten Rapp
- Department of Chemical Engineering, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA
| | - Allan Myerson
- Department of Chemical Engineering, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA.
| |
Collapse
|
12
|
Russo D, Di Somma I, Marotta R, Tomaiuolo G, Andreozzi R, Guido S, Lapkin AA. Intensification of Nitrobenzaldehydes Synthesis from Benzyl Alcohol in a Microreactor. Org Process Res Dev 2017. [DOI: 10.1021/acs.oprd.6b00426] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
Affiliation(s)
- Danilo Russo
- Dipartimento
di Ingegneria Chimica, dei Materiali e della Produzione Industriale, Università di Napoli Federico II, p.le V. Tecchio, 80−80125 Napoli, Italy
- Department
of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge CB2 1TN, United Kingdom
| | - Ilaria Di Somma
- Istituto di Ricerche sulla Combustione (CNR), p.le V. Tecchio, 80−80125 Napoli, Italy
| | - Raffaele Marotta
- Dipartimento
di Ingegneria Chimica, dei Materiali e della Produzione Industriale, Università di Napoli Federico II, p.le V. Tecchio, 80−80125 Napoli, Italy
| | - Giovanna Tomaiuolo
- Dipartimento
di Ingegneria Chimica, dei Materiali e della Produzione Industriale, Università di Napoli Federico II, p.le V. Tecchio, 80−80125 Napoli, Italy
| | - Roberto Andreozzi
- Dipartimento
di Ingegneria Chimica, dei Materiali e della Produzione Industriale, Università di Napoli Federico II, p.le V. Tecchio, 80−80125 Napoli, Italy
| | - Stefano Guido
- Dipartimento
di Ingegneria Chimica, dei Materiali e della Produzione Industriale, Università di Napoli Federico II, p.le V. Tecchio, 80−80125 Napoli, Italy
| | - Alexei A. Lapkin
- Department
of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge CB2 1TN, United Kingdom
| |
Collapse
|